IPO registrations (S-1, F-1) · Registrants
DELCATH SYSTEMS, INC.
- SEC CIK
- 872912 · filings on EDGAR ↗
- Former names
- DELCATH SYSTEMS INC (2000–2013)
- Registration
- Form S-1, first filed 2015-06-15, last 2020-05-01; 9 initial registrations, 20 amendments
- Outcome
- Final prospectus filed 2015-07-17; declared effective 2015-07-15; withdrawal requested 2018-06-12
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 566 QUEENSBURY AVENUE, Queensbury, NY 12804
- EIN
- 06-1245881
- Ticker
- DCTH (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- DELCATH SYSTEMS, INC. on the corporate pages
On this site
- Business registration: DELCATH SYSTEMS, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: DELCATH SYSTEMS, INC Fuzzy (name and state)
- Business registration: DELCATH SYSTEMS, INC. Fuzzy (name and state)
- Business registration: DELCATH SYSTEMS, INC. Fuzzy (name and state)
- Business registration: DELCATH SYSTEMS, INC. Fuzzy (name and state)
- Business registration: DELCATH SYSTEMS, INC. Fuzzy (name and state)
- Business registration: DELCATH SYSTEMS, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: DELCATH SYSTEMS INC. EXACT (EIN (EXACT))
- Form D issuer: DELCATH SYSTEMS, INC. EXACT (CIK (EXACT))
- Lobbying client: DELCATH SYSTEMS Fuzzy (name and state)
- Lobbying client: DELCATH SYSTEMS, INC. Fuzzy (name and state)
- SEC filer: DELCATH SYSTEMS INC EXACT (CIK (EXACT))
- Person page: Douglas G Watson Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Eamonn P Hobbs Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer))
- Person page: Pamela Reilly Contag Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 50
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2015-06-15 | S-1 | S-1 (registration) | DELCATH SYSTEMS, INC. | 0001193125-15-223513 ↗ |
| 2015-07-02 | S-1/A | S-1/A (amendment) | DELCATH SYSTEMS, INC. | 0001193125-15-244392 ↗ |
| 2015-07-07 | S-1/A | S-1/A (amendment) | DELCATH SYSTEMS, INC. | 0001193125-15-246881 ↗ |
| 2015-07-15 | S-1/A | S-1/A (amendment) | DELCATH SYSTEMS, INC. | 0001193125-15-252535 ↗ |
| 2015-07-15 | EFFECT | EFFECT (declared effective) | DELCATH SYSTEMS, INC. | 9999999995-15-001928 ↗ |
| 2015-07-17 | 424B4 | 424B4 (final prospectus) | DELCATH SYSTEMS, INC. | 0001193125-15-255162 ↗ |
| 2015-10-20 | EFFECT | EFFECT (declared effective) | DELCATH SYSTEMS, INC. | 9999999995-15-002810 ↗ |
| 2016-05-13 | EFFECT | EFFECT (declared effective) | DELCATH SYSTEMS, INC. | 9999999995-17-000663 ↗ |
| 2017-10-11 | S-1 | S-1 (registration) | DELCATH SYSTEMS, INC. | 0001193125-17-307479 ↗ |
| 2017-11-02 | S-1/A | S-1/A (amendment) | DELCATH SYSTEMS, INC. | 0001193125-17-331279 ↗ |
| 2018-01-17 | S-1/A | S-1/A (amendment) | DELCATH SYSTEMS, INC. | 0001193125-18-012316 ↗ |
| 2018-01-26 | S-1/A | S-1/A (amendment) | DELCATH SYSTEMS, INC. | 0001193125-18-021757 ↗ |
| 2018-02-05 | S-1/A | S-1/A (amendment) | DELCATH SYSTEMS, INC. | 0001193125-18-032081 ↗ |
| 2018-02-06 | S-1/A | S-1/A (amendment) | DELCATH SYSTEMS, INC. | 0001193125-18-033446 ↗ |
| 2018-02-07 | EFFECT | EFFECT (declared effective) | DELCATH SYSTEMS, INC. | 9999999995-18-000352 ↗ |
| 2018-02-12 | 424B4 | 424B4 (final prospectus) | DELCATH SYSTEMS, INC. | 0001193125-18-038922 ↗ |
| 2018-04-09 | S-1 | S-1 (registration) | DELCATH SYSTEMS, INC. | 0001193125-18-111656 ↗ |
| 2018-06-12 | RW | RW (withdrawal request) | DELCATH SYSTEMS, INC. | 0001193125-18-189822 ↗ |
| 2018-06-12 | S-1 | S-1 (registration) | DELCATH SYSTEMS, INC. | 0001193125-18-189824 ↗ |
| 2018-07-13 | S-1/A | S-1/A (amendment) | DELCATH SYSTEMS, INC. | 0001193125-18-217976 ↗ |
| 2018-07-30 | S-1/A | S-1/A (amendment) | DELCATH SYSTEMS, INC. | 0001193125-18-231651 ↗ |
| 2018-08-01 | S-1/A | S-1/A (amendment) | DELCATH SYSTEMS, INC. | 0001193125-18-234993 ↗ |
| 2018-08-03 | EFFECT | EFFECT (declared effective) | DELCATH SYSTEMS, INC. | 9999999995-18-002002 ↗ |
| 2018-08-06 | 424B4 | 424B4 (final prospectus) | DELCATH SYSTEMS, INC. | 0001193125-18-239604 ↗ |
| 2018-08-07 | 424B4 | 424B4 (final prospectus) | DELCATH SYSTEMS, INC. | 0001193125-18-241277 ↗ |
| 2018-08-09 | 424B4 | 424B4 (final prospectus) | DELCATH SYSTEMS, INC. | 0001193125-18-243929 ↗ |
| 2018-08-15 | S-1 | S-1 (registration) | DELCATH SYSTEMS, INC. | 0001193125-18-249743 ↗ |
| 2018-09-18 | S-1/A | S-1/A (amendment) | DELCATH SYSTEMS, INC. | 0001193125-18-276631 ↗ |
| 2018-09-26 | EFFECT | EFFECT (declared effective) | DELCATH SYSTEMS, INC. | 9999999995-18-002464 ↗ |
| 2018-12-21 | EFFECT | EFFECT (declared effective) | DELCATH SYSTEMS, INC. | 9999999995-18-003205 ↗ |
| 2019-08-21 | S-1 | S-1 (registration) | DELCATH SYSTEMS, INC. | 0001193125-19-226162 ↗ |
| 2019-09-25 | S-1/A | S-1/A (amendment) | DELCATH SYSTEMS, INC. | 0001193125-19-254834 ↗ |
| 2019-10-30 | S-1/A | S-1/A (amendment) | DELCATH SYSTEMS, INC. | 0001193125-19-277808 ↗ |
| 2019-11-01 | S-1/A | S-1/A (amendment) | DELCATH SYSTEMS, INC. | 0001193125-19-282044 ↗ |
| 2019-11-07 | EFFECT | EFFECT (declared effective) | DELCATH SYSTEMS, INC. | 9999999995-19-002517 ↗ |
| 2019-12-30 | S-1 | S-1 (registration) | DELCATH SYSTEMS, INC. | 0001193125-19-326056 ↗ |
| 2020-01-06 | S-1/A | S-1/A (amendment) | DELCATH SYSTEMS, INC. | 0001193125-20-002232 ↗ |
| 2020-01-07 | EFFECT | EFFECT (declared effective) | DELCATH SYSTEMS, INC. | 9999999995-20-000028 ↗ |
| 2020-01-13 | S-1 | S-1 (registration) | DELCATH SYSTEMS, INC. | 0001193125-20-006392 ↗ |
| 2020-01-27 | S-1 | S-1 (registration) | DELCATH SYSTEMS, INC. | 0001193125-20-015434 ↗ |
| 2020-02-07 | S-1/A | S-1/A (amendment) | DELCATH SYSTEMS, INC. | 0001193125-20-028323 ↗ |
| 2020-04-20 | S-1/A | S-1/A (amendment) | DELCATH SYSTEMS, INC. | 0001193125-20-111603 ↗ |
| 2020-04-23 | S-1/A | S-1/A (amendment) | DELCATH SYSTEMS, INC. | 0001193125-20-117135 ↗ |
| 2020-04-30 | EFFECT | EFFECT (declared effective) | DELCATH SYSTEMS, INC. | 9999999995-20-000921 ↗ |
| 2020-05-01 | S-1/A | S-1/A (amendment) | DELCATH SYSTEMS, INC. | 0001193125-20-131135 ↗ |
| 2020-05-04 | 424B4 | 424B4 (final prospectus) | DELCATH SYSTEMS, INC. | 0001193125-20-132561 ↗ |
| 2020-05-05 | 424B4 | 424B4 (final prospectus) | DELCATH SYSTEMS, INC. | 0001193125-20-133731 ↗ |
| 2020-05-05 | EFFECT | EFFECT (declared effective) | DELCATH SYSTEMS, INC. | 9999999995-20-001035 ↗ |
| 2021-07-02 | EFFECT | EFFECT (declared effective) | DELCATH SYSTEMS, INC. | 9999999995-21-002645 ↗ |
| 2021-10-18 | EFFECT | EFFECT (declared effective) | DELCATH SYSTEMS, INC. | 9999999995-21-003928 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| HERSCHKOWITZ SAMUEL /FA/ | Director; Director,Officer | Chief Operating Officer; Chief Technical Officer; Interim COO | 4 | 2006–2007 | |
| CORIGLIANO MARK | Director | 4 | 2006–2007 | ||
| LADD ROBERT | Director; Director,TenPercentOwner; TenPercentOwner | 60 | 2006–2012 | ||
| KOLY M S /FA/ | Director; Director,Officer | President and CEO | 4 | 2006–2007 | |
| ISDANER DANIEL | Director | 4 | 2006–2007 | ||
| Koplewicz Harold S | Director | 17 | 2006–2015 | ||
| NEVINS VICTOR | Director | 2 | 2006 | ||
| Taney Richard | Director; Director,Officer | Chief Executive Officer; Interim CEO | 19 | 2006–2009 | |
| Philips Laura A | Director | 18 | 2007–2015 | ||
| LEWIS JONATHAN | Director | 3 | 2007–2008 | ||
| FEINSTEIN PAUL M | Officer | Chief Financial Officer | 1 | 2007 | |
| HOBBS EAMONN P | Director; Director,Officer | Pres. & Chief Exec. Officer; President and CEO | 8 | 2008–2013 | person page Fuzzy |
| STOLL ROGER G PHD | Director | 23 | 2008–2024 | ||
| Contag Pamela Reilly | Director | 4 | 2009–2010 | person page Fuzzy | |
| Rifkin Jason Andrew | Officer | Sr. VP Clinical Oper. & Secy | 2 | 2009 | |
| Keck Barbra | Officer | Chief Financial Officer; Controller; See Remarks; Senior VP, Finance; Vice President, Controller | 17 | 2009–2020 | |
| McDonald David | Officer | Chief Financial Officer | 4 | 2009–2011 | |
| Kandarpa Krishna | Officer | Exec. V.P., Chief Medical Off. | 7 | 2009–2013 | |
| GAGO AGUSTIN V | Officer | EVP Global Sales & Marketing | 5 | 2010–2013 | |
| Purpura John | Officer | Chief Operating Officer; CHIEF OPERATING OFFICER; EVP, Global Operations; EVP Reg. Affairs/Quality Assur; EVP, Regulatory Affairs; See Remarks | 25 | 2010–2024 | |
| GRAHAM PETER J | Officer | EVP; General Counsel | 6 | 2010–2013 | |
| WATSON DOUGLAS G | Director | 10 | 2010–2014 | person page Fuzzy | |
| LEUNG GABRIEL | Director | 8 | 2011–2014 | ||
| MAPES HAROLD | Officer | Exec. V. P., Global Operations | 4 | 2011–2013 | |
| Miao Graham G | Officer | Exec. V.P., CFO; Interim Co-CEO & Pres.EVP, CFO | 7 | 2011–2013 | |
| Simpson Jennifer K. | Director,Officer; Officer | Director, President & CEO; Exec. VP, Global Marketing; Interim Co-CEO&Pres.EVP Market; President and CEO; President & CEO | 14 | 2012–2020 | |
| Brege Laura | Director | 4 | 2012–2014 | ||
| Konidaris Tasos | Director | 4 | 2012–2014 | ||
| APPLING WILLIAM M | Officer | EVP, R&D and Global Operations | 3 | 2013 | |
| LANGER DENNIS | Director | 3 | 2014–2015 | ||
| Taglietti Marco | Director | 7 | 2014–2020 | ||
| Rueckert William Dodge | Director | 10 | 2014–2020 | ||
| Pedder Simon | Director | 1 | 2019 | ||
| Sylvester John Richard | Director | 10 | 2019–2026 | ||
| CZEREPAK ELIZABETH | Director | 8 | 2020–2026 | ||
| Aharon Gil | Director; DirectorOther | 30 | 2020–2026 | ||
| Rosalind Advisors, Inc. | Director; DirectorOther | 26 | 2020–2025 | ||
| SALAMON STEVEN A J | Director; DirectorOther | 42 | 2020–2026 | ||
| Padula Christine | Officer | See Remarks | 3 | 2020–2021 | |
| MICHEL GERARD J | Director,Officer | Chief Executive Officer; CHIEF EXECUTIVE OFFICER; See Remarks | 24 | 2020–2026 | |
| John Johnny | Officer | See Remarks; SVP CLINICAL DEV & MED AFFAIRS | 4 | 2022–2024 | |
| Muir Kevin | Officer | GM INTERVENTIONAL ONCOLOGY; See Remarks; VP COMMERCIAL OPERATIONS | 7 | 2022–2026 | |
| Dias Anthony | Officer | Vice President of Finance; VP FINANCE | 2 | 2022–2024 | |
| Hoffman David L. | Officer | GEN'L COUNSEL, CCO & SECY; See Remarks | 8 | 2022–2026 | |
| Pennell Sandra | Officer | Chief Financial Officer; See Remarks; SVP of Finance, PFO and PAO; SVP OF FINANCE, PFO AND PAO | 8 | 2023–2026 | |
| Vukovic Vojo | Officer | Chief Medical Officer; CHIEF MEDICAL OFFICER; See Remarks | 8 | 2023–2026 | |
| Rook Martha S. | Officer | CHIEF OPERATING OFFICER | 4 | 2024–2026 | |
| Martell Bridget A | Director | 4 | 2024–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2024-03-26 | DELCATH SYSTEMS, INC. | Biotechnology | $7,001,113 | $7,001,113 | 17 | 1 |
| 2023-03-31 | DELCATH SYSTEMS, INC. | Biotechnology | $24,999,999 | $24,999,999 | 17 | 1 |
| 2022-12-16 | DELCATH SYSTEMS, INC. | Biotechnology | $3,807,499 | $3,807,499 | 7 | 1 |
| 2022-07-22 | DELCATH SYSTEMS, INC. | Biotechnology | $4,999,999 | $4,999,999 | 6 | 1 |
| 2019-08-27 | DELCATH SYSTEMS, INC. | Biotechnology | $9,510,434 | $9,510,434 | 33 | 1 |
| 2019-07-25 | DELCATH SYSTEMS, INC. | Biotechnology | $20,000,000 | $20,000,000 | 31 | 1 |
| 2018-08-03 | DELCATH SYSTEMS, INC. | Biotechnology | $1,600,000 | $1,600,000 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.